2 ml pre-filled syringe

INNOVATIVE TREATMENTS BASED ON HIGH VISCOSITY LINEAR HYALURONIC ACID FOR JOINTS AFFECTED BY OA

ALLEVYAL® is an injectable product containing a buffered solution of hyaluronic acid sodium salt with an average molecular weight of 1,500 kDaltons, with notable viscoelastic properties. Obtained through the biofermentation of Streptococcus equi, the sodium hyaluronate in Allevyal® is rigorously purified.

TREATMENT OF THE AFFECTED JOINTS

Allevyal®'s pre-filled and sterilized disposable glass syringes differ from those of other competitors, whose hyaluronic acid milligram range varies between 15-18 mg/ml: the quantity of HA present in our product is a whopping 20 mg/ml.

It is available in two formats:
• Allevyal 2ml - containing 40 mg of hyaluronic acid in 2 ml of buffer solution (2%)
• Allevyal 4ml - containing 80 mg of hyaluronic acid in 4 ml of buffer solution (2%)

Allevyal 2ml

EU Classification: Class III Medical Device
HA Molecular Chain: Linear
Origin: Biofermentation (Streptococcus Equi)
HA Concentration: 40mg/2ml (2%)
Molecular Weight: 1500 KDa
Volume (pre-filled syringe): 2ml
Indications: Treatments for all joints such as knee, hip, shoulder, fingers
Packaging: Airless system (High Safety Profiles)

Dosage: 2 annual therapies with 2-3 injections, one every 15 days

At the doctor's discretion and depending on the patient's condition, multiple joints may be treated simultaneously. A minimum of 6 months between any further treatment cycles is required.

RESULTS
Reduction of symptoms such as pain and swelling
Recovery of joint functionality
Healing and preventive effect on tissues
Excellent tolerability
Local and non-systemic action